We're hiring!
Two opportunities to join team: Senior Health Economist & Research Nurse
ED@crukcambridgecentre.org.uk
01223 763384
Members Area
Members Area
ED@crukcambridgecentre.org.uk
01223 763384
Members Area
Members Area
• The BEST3 trial: is the Cytosponge TFF3 biomarker test oven-ready for primary care? More information
• New model predicts oesophageal cancer eight years early for one in two patients. More information
• Cytosponge and BEST 3 trial feature on Look East, 4th August. More infomation
When cancer is found earlier it can be easier to treat successfully. Statistics from Cancer Research UK show that the ten-year survival rate for eight different types of cancer combined is more than three times higher if the disease is diagnosed at stage one or two, compared with survival rates when diagnosed at stage three or four.
The highly multidisciplinary CRUK Cambridge Centre Early Detection Programme engages world class researchers in projects to better understand the biology of the disease, to find it earlier and to reduce the number of deaths caused by cancer. In addition, the programme's social science researchers are exploring the broader implications (psychological, legal, economic etc.) of early detection and prevention strategies for the individual and society.